Return to Publications
RWJBarnabas HealthRutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including clinical trials and novel therapeutics such as precision medicine and immunotherapy.

Return to Publications  |  Return to CINJ Home
The Cancer Institute of New Jersey's Cancer Connection, November 2013

Your link to the latest news on research, treatment, prevention and education from the state's only

National Cancer Institute-designated Comprehensive Cancer Center



Zebrafish Shown to be Useful Tool in Prostate Cancer Stem Cell Research



Research from Rutgers Cancer Institute of New Jersey demonstrates that using zebrafish to identify self-renewing tumor stem cells in prostate cancer may be more beneficial than using traditional experimental models when aiming to predict response to therapy. The study, by senior author and Cancer Institute scientist Hatem E. Sabaawy, MD, PhD, and colleagues, appears in the latest edition of The Prostate.Learn more

Gynecologic Oncology Team Expands at Rutgers Cancer Institute of
New Jersey



Sara Isani, MD, recently joined the Gynecologic Oncology Program at Rutgers Cancer Institute of New Jersey. Dr. Isani attended New York University's School of Medicine, completed her residency at the Yale New Haven Hospital and fellowship in gynecologic oncology at the Albert Einstein College of Medicine. Dr. Isani will provide evaluation and services to patients with cancers in the female reproductive tract who are seen in the Gynecologic Oncology Program.Learn more

Researchers Awarded Nearly $2.5M to Examine Ways to Block Cancer Cell Growth



A pair of researchers at Rutgers Cancer Institute of New Jersey has been awarded nearly $2.5 million dollars from the National Institutes of Health to further study in their respective laboratories. X.F. Steven Zheng, PhD, was awarded $1.65 million to examine an activating mechanism of the mTOR protein, which is a central controller of cell growth and metabolism. Darren R. Carpizo, MD, PhD, was awarded nearly $800,000 to explore a compound found to restore tumor suppressor function of a mutated p53 gene in cancer cells.Learn more

Pillars of Excellence Honored



As part of the annual Award of Hope Gala held last month and in celebration of Rutgers Cancer Institute of New Jersey's 20th anniversary of patient care, 20 'Pillars of Excellence' were nominated by their peers and honored for upholding the core values and mission of the Cancer Institute.View the list

            Rutgers Cancer Institute of New Jersey                                          NCI logo 

Office of Communications         ·        ·        732-235-9871

                        Like us on Facebook                     Join the CINJ Mailing List